To any Hmong and Montagnard war veterans reading this article, thank you and God bless you for your service and sacrifice.

Nov. 27, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that ...

Shares of Arvinas (ARVN) are up about 3% in pre-market trading at $18.40. Last night, in a 13G filing, Citadel Securities disclosed a 5.1% holding in Arvinas, which represents about 3.48M shares.

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

The Geneva conference that ended the Indo-China war left unsettled the status of the Communist-directed movement called Pathet Lao (estimated membership: 6,000), whose olive-green “resistance ...

The Werner Herzog directorial is a biographical war drama based on the events in the life of German-born United States Navy aviator Dieter Dengler after he was shot down and captured by the communist ...

Arvinas Holding Company (ARVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jeet Mukherjee from BTIG reiterated a Buy rating on the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...